June 1-5, 2018
June 1-5, 2018
Dr. Tammy Clifford, CADTH, Canada
Dr. Tammy Clifford is CADTH’s Chief Scientist and Vice-President, Evidence Standards. Over the past dozen years, she has served in a number of senior leadership roles at CADTH, with responsibility for the agency’s Health Technology Assessment (HTA), Horizon Scanning, Rapid Response, Scientific Advice and Patient Engagement programs. Tammy received her PhD in Epidemiology & Biostatistics at the University of Western Ontario, and her BSc and MSc from McGill. Through her role as an adjunct professor with the School of Epidemiology, Public Health & Preventive Medicine at the University of Ottawa, Tammy is building awareness of and capacity in HTA through her active involvement with the graduate program. She has been actively involved with national and international HTA activities, including having served on the Board of Directors of Health Technology Assessment international (HTAi), and having participated in the development of the scientific programmes for many HTAi annual meetings. Tammy is also an Associate Editor with IJTAHC. She is internationally recognized for her passion and commitment to advancing the science of HTA, and to mentoring the next generation of HTA producers.
Dr. Alric Rüther, IQWiG, Germany
Alric Rüther is a physician trained in Internal Medicine and Oncology. Based on his engagement in Evidence Based Medicine and Cochrane Collaboration he worked to establish and build the discipline of Health Technology Assessment in Germany. Alric is founder of the German Agency for HTA (DAHTA) at DIMDI, Federal Ministry of Health. In 2007 Alric changed to the Institute of Quality and Efficiency in Health Care (IQWiG) heading the Department of Health Care Quality. Main task of the department was to identify and describe Health Care Standards based on Clinical Practice Guidelines, i.e. as scientific background for Disease Management Programs (DMP). Additional Alric was responsible for the development and maintenance of the international relationships of IQWiG. This leads to the establishment of the department of International Affairs at IQWiG in 2015 which Alric is leading now. Alric has been engaged in worldwide HTA development for more than 10 years: with the HTAi since its founding (member of the Board since 2013; chair of Annual Meeting Committee 2016-2017; from 2017chair of Scientific Development and Capacity Building Advisory Committee); INAHTA (vice chair until 2006, chair of internal communications 2005 – 2016), EUnetHTA (founding member; chair of plenary 2010-12; Lead Partner Quality Management, Scientific Guidance and Tools [WP6] Joint Action 3 from 2016) and ISPOR (chair of HTA roundtable Europe 2013-2016). Alric is an associate professor at the Universities of Bielefeld and Berlin, lecturing HTA.
Dr. Nick Bansback
University of British Columbia, Canada
Mr. Ken Bond
CADTH, Canada
Ms. Mirella Marlow
NICE, UK
Dr. Oriana Ciani
University of Exeter, UK
Dr. Fiona Clement
University of Calgary, Canada
Ms. Sophie Cros
Abbott, Belgium
Dr. Paul Fennessy
Dept. of Health & Human Services, Australia
Dr. Rabia Kahveci
ANHTA, Turkey
Dr. Sebastian Garcia Marti
IECS, Argentina
Dr. Newell McElwee
Boehringer-Ingleheim, USA
Ms. Debjani Mueller
WHO, South Africa
Dr. Daniel Ollendorf
ICER, USA
Dr. Keng Ho Pwee
Eastern Health, Singapore
Dr. Máirín Ryan
HIQA, Ireland
Dr. Bettina Ryll
Melanoma Patient Network Europe, Sweden
Dr. Dima Samaha
LA-SER Analytica, UK
Dr. Sangjin Shin
NECA, South Korea
Dr. Sean Sullivan
University of Washington, USA
Dr. Sophie Werkö
SBU, Sweden